Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients

Transplantation

Volumn 60, Issue 12, 1995, Pages 1438-1442

  Dunn, Stephen P ^a   Cooney, Gerard F ^a   Kulinsky, Anatoly ^a   Falkenstein, Kathleen ^a   Pierson, Andrea ^a   Elder, Cheryl A ^b   Meligeni, John ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CROSSOVER PROCEDURE; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG CONCENTRATION; DRUG DEVELOPMENT; DRUG DOSE; DRUG EFFICACY; DRUG FORMULATION; DRUG THERAPY; EMULSION; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; CYCLOSPORINE; DOUBLE-BLIND METHOD; EMULSIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INJECTIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE;

EID: 0029568081     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199560120-00012     Document Type: Article

References (23)

1. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
2. Ptachcinski RJ, Venkataramanan R, Burckard GJ. Clinical pharmacokinetics of cyclosporine. Clin Pharmacokinet 1986; 11: 107.
3. Shaw LM, Yatscoff RW, Bowers LD, et al. Canadian consensus meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem 1990; 36: 1841.
4. Kahan BD, Shaw LM, Holt D, Grevel J, Johnston A. Consensus document: Hawk’s Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 1990; 36: 1510.
5. Kasiske BL, Heim-Duthoy K, Rao RV, Awni WM. The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients. Transplantation 1988; 46: 716.
6. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54: 205.
7. Hoppu K, Koskimies O, Holmberg C, Hirvisalo E. Evidence for pre-hepatic metabolism of oral cyclosporine A in children. Br J Clin Pharmacol 1991; 32: 477.
8. Cooney GF, Mochon M, Kaiser B, Dunn SP, Goldsmith B. Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients. Pharmacotherapy 1995; 15: 353.
9. Lindholm A, Hendrickson S, Lisel M, Dahlquest R. Interindividual variability in the relative systemic availability of cyclosporine after oral dosing. Eur J Clin Pharmacol 1988; 35: 461.
10. Venkataramanan R, Starzl T, Yang S, et al. Biliary excretion of cyclosporine in liver transplant patients. Transplant Proc 1985; 17: 286.
11. Gupta SK, Manfro RC, Tomlanovich, Gambertoglio JG, Garovoy MR, Benet LZ. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J Clin Pharmacol 1990; 30: 643.
12. Cooney GF, Dunn SP, Kaiser B, Kulinsky AV, Mochon M, Heifets M. Oral cyclosporine pharmacokinetics in pediatric renal transplant recipients. Transplant Proc 1994; 26: 2779.
13. Kahan BD, Dunn J, Fitts C, Van Buren D, et al. The Neoral formulation’s improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Transplant Proc 1994; 26: 2940.
14. Belli LS, Slim OA, DeCarlis L, Rondinara GF, et al. Neoral in liver transplant patients: pharmacokinetic study and clinical implications. Transplant Proc 1994; 26: 298.
15. Trull AK, Tan KKC, Tan L, Alexander GJM, Jamieson NV. Enhanced absorption of a new cyclosporine microemulsion formulation, Neoral, in liver transplant recipients with external biliary drainage. Transplant Proc 1994; 26: 2977.
16. Farber L, Maibucher A, Geissler F, Gutzler F, Wiesenger FO, Winkler M. Favorable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients. Transplant Proc 1994; 26: 2988.
17. Fiocchi R, Mamprin F, Gamba A, Glorber S, et al. Pharmacokinetic profiles of cyclosporine in long-term transplanted patients treated with a new oral formulation. Transplant Proc 1994; 26: 2994.
18. Yee GC, McGuire TR. Pharmacokinetic interactions with cyclosporine. Clin Pharmacokinetics 1990; 19: 319.
19. Benet LZ, Galeazzi RL. Non-compartmental determination of the steady-state volume of distribution. J Pharm Sci 1979; 68: 1071.
20. Rocci Jr ML, Jusko WJ. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Prog Biomed 1983; 16: 203.
21. Dalere GM, Lum BL, Cooney GF, Wong-Chin M. Comparison of three methods for CsA: area under the curve monitoring calculations. Ther Drug Monit 1995; 17: 305.
22. Hoppu K, Koskimies O, Holmberg C, Hirvisalo L. Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 1991; 5: 1.
23. Whitington PF, Emond JC, Whitington SH, Broelsch CE, Baker AL. Small bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med 1990; 322: 733.